{"abdominal rigidity": 5.92, "acute myeloid leukaemia": 6.46, "acute respiratory distress syndrome": 3.35, "adenocarcinoma": 6.64, "agranulocytosis": 26.39, "alopecia": 6.61, "alopecia areata": 31.66, "alopecia totalis": 35.41, "anaemia": 3.2, "bacteraemia": 2.48, "bicytopenia": 25.92, "bone lesion": 5.49, "bone marrow failure": 2.7, "bone pain": 2.02, "breast cancer": 3.5, "breast cancer metastatic": 11.67, "breast cancer recurrent": 13.93, "capillary leak syndrome": 6.16, "cardiac dysfunction": 3.46, "cardiac failure": 2.19, "cardiomyopathy": 2.57, "cardiotoxicity": 21.03, "colitis": 2.83, "colitis ischaemic": 2.52, "cytopenia": 5.07, "dacryostenosis acquired": 190.46, "decreased appetite": 2.28, "dermatitis": 2.14, "dermatitis acneiform": 2.29, "device related infection": 3.11, "diarrhoea": 3.03, "dilated cardiomyopathy": 2.24, "disease progression": 6.79, "drug-induced liver injury": 2.57, "dry eye": 2.16, "ejection fraction decreased": 17.42, "enteritis": 6.76, "enterocolitis": 7.42, "febrile bone marrow aplasia": 13.23, "febrile neutropenia": 26.17, "flushing": 5.39, "foreign body sensation in eyes": 6.27, "gastrointestinal toxicity": 12.12, "granulocyte count decreased": 48.61, "granulocytopenia": 27.93, "haematotoxicity": 12.45, "hair colour changes": 47.07, "hair texture abnormal": 93.41, "hepatic function abnormal": 5.3, "hepatic lesion": 4.54, "hormone-refractory prostate cancer": 13.56, "hypoalbuminaemia": 2.97, "hypocalcaemia": 4.15, "hypokalaemia": 3.09, "hypomagnesaemia": 3.21, "hypophagia": 2.27, "infusion related reaction": 4.34, "injury": 5.01, "interstitial lung disease": 3.74, "invasive ductal breast carcinoma": 11.63, "lacrimal structure injury": 2437.01, "lacrimation increased": 9.28, "large intestine perforation": 5.04, "left ventricular dysfunction": 10.98, "leukopenia": 9.97, "liver injury": 2.96, "lung adenocarcinoma": 8.23, "lymphocyte count decreased": 2.2, "lymphopenia": 2.75, "madarosis": 89.71, "malignant neoplasm progression": 4.31, "metastases to bone": 12.33, "metastases to central nervous system": 7.47, "metastases to liver": 8.82, "metastases to lung": 11.47, "metastases to lymph nodes": 13.24, "metastases to pleura": 12.44, "metastases to skin": 11.68, "metastases to spine": 6.14, "metastases to the mediastinum": 28.2, "metastasis": 11.38, "mouth ulceration": 2.33, "mucosal inflammation": 13.2, "myelodysplastic syndrome": 4.38, "myelosuppression": 59.74, "nail discolouration": 8.61, "nail disorder": 20.1, "neoplasm progression": 2.09, "neoplasm recurrence": 5.39, "neuropathy peripheral": 5.5, "neurotoxicity": 3.6, "neutropenia": 9.71, "neutropenic colitis": 30.89, "neutropenic sepsis": 8.53, "neutrophil count decreased": 36.14, "neutrophil count increased": 2.65, "non-small cell lung cancer": 8.91, "oesophagitis": 2.9, "onycholysis": 38.92, "osteonecrosis of jaw": 2.27, "palmar-plantar erythrodysaesthesia syndrome": 6.01, "paronychia": 4.69, "peripheral sensory neuropathy": 5.08, "peritonitis": 2.57, "platelet count decreased": 2.15, "pleural effusion": 3.03, "pneumatosis intestinalis": 6.85, "pneumonitis": 2.18, "polyneuropathy": 8.08, "portal venous gas": 113.0, "prostate cancer": 4.23, "prostate cancer metastatic": 14.9, "prostatic specific antigen increased": 8.23, "pulmonary fibrosis": 2.08, "pulmonary mass": 3.12, "second primary malignancy": 6.1, "septic shock": 4.96, "sinus tachycardia": 2.31, "skin exfoliation": 2.74, "skin toxicity": 8.98, "stomatitis": 6.2, "subclavian vein thrombosis": 15.77, "systemic scleroderma": 17.17, "therapy partial responder": 5.91, "thrombocytopenia": 2.13, "toxic skin eruption": 3.76, "transaminases increased": 2.42, "tumour lysis syndrome": 2.72, "vascular device infection": 4.7, "white blood cell count decreased": 28.86}